-
En Carta Diagnostics receives FDA Breakthrough Device Designation for EC Pocket Lyme test
Breakthrough device status for rapid, Point-of-Need molecular diagnostic platform will fill critical gap in early-stage detection of Borrelia bacteria, the...
Join our audience of
healthcare industry professionals